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Background: Transcranial magnetic stimulation combined with electroencephalography 2 
(TMS-EEG) is a powerful tool to probe human cortical excitability. The EEG response to TMS 3 
stimulation is altered by drugs active in the brain, with characteristic “fingerprints” obtained 4 
for drugs of known mechanisms of action. However, the extraction of specific features related 5 
to drug effects is not always straightforward as the complex TMS-EEG induced response 6 
profile is multi-dimensional, indexed over space, time, frequency, subjects and drug 7 
conditions. Analytical approaches can rely on a-priori assumptions within each dimension or 8 
on the implementation of cluster-based permutations which do not require preselection of 9 
specific limits but may be problematic when several experimental conditions are tested.  10 
Methods: We here propose an alternative data-driven approach based on PARAFAC tensor 11 
decomposition, which provides a parsimonious description of the main profiles underlying 12 
the multidimensional data. We validated reliability of PARAFAC on TMS-induced oscillations 13 
before extracting the features of two common anti-epileptic drugs (levetiracetam and 14 
lamotrigine) in an integrated manner.  15 
Results: PARAFAC revealed an effect of both drugs, significantly suppressing oscillations in 16 
the alpha range in the occipital region. Further, this effect was stronger under the intake of 17 
levetiracetam. 18 
Conclusions: This study demonstrates, for the first time, that PARAFAC can easily disentangle 19 








1. Introduction 1 
Transcranial magnetic stimulation (TMS) is a non-invasive tool to probe neurophysiological 2 
processes in the human brain. A TMS pulse depolarizes the stimulated neuronal population 3 
and remote anatomically connected regions 1. The registration of TMS effects with 4 
electroencephalography (EEG) allows to quantify and characterize spread of neural activation 5 
that follows in time, spatial and frequency domains 2. The summation of synaptic potentials 6 
produces a series of time-locked positive and negative deflections visible in the EEG signal, 7 
termed the TMS-evoked potentials (TEPs). TEPs are a sequence of peaks which reflect cortical 8 
reactivity and changes in their amplitude and latency reflect changes in cortical activity 3. In 9 
addition, brain responses to TMS can be interrogated applying a time-frequency analysis at 10 
single trial level removing the evoked (i.e. TEPs) component from the signal. TMS-induced 11 
oscillations are the result of this analytical approach and they provide non-phase locked 12 
neural information 4. 13 
TEPs and TMS-induced oscillations are outcome measures used to characterise brain states 14 
in health, diseases and under experimental conditions such as drug manipulation 5. Previous 15 
work showed that TMS-EEG is a powerful tool to investigate effects of drugs acting in the 16 
human brain 6-10. In these studies, the effects of drugs were quantified in term of differences 17 
between conditions (or subjects) in evoked activity in specific time windows corresponding 18 
to TEPs and in specific sets of EEG electrodes. A cluster based permutation approach is the 19 
golden standard used to overcome the problem of multiple comparisons. It requires an a-20 
priori selection of time windows or a post-hoc correction for the large number of non-21 
independent comparisons across many tested conditions. It seems highly likely that 22 
important effects will be lost through inadvertent selection of the “wrong” time windows 23 
and/or electrodes, or through the necessarily harsh post-hoc correction for multiple non-24 
independent comparisons.  25 
The high dimensionality of TMS-EEG data is a challenge for analysis and interpretation, and 26 
motivates approaches to simplify the data by reducing the dimensionality. Specifically, we can 27 
hypothesise that TMS stimulation of the brain gives rise to activity in specific brain networks 28 
following stimulation, and that these networks will have a specific spatial distribution and 29 
specific spectral characteristics (i.e. the network operates in a particular frequency range) – 30 
but identifing such underlying patterns in highly multidimensional data is difficult. Here, we 1 
apply a methodology based on tensor decomposition to reveal such underlying patterns.  2 
The term “tensor” refers to a multi-way (i.e. multidimensional) array, that is a collection of 3 
variables that can be indexed by more than two terms. Whereas the position of and element 4 
in a vector or matrix is determined, respectively, by one (e.g., i) or two indices (e.g., i,j) , the 5 
values in a tensor are indexed by more than two parameters: i, j, k 11. In a similar way to how 6 
matrix decompositions (e.g., principal component analysis) can represent a two-dimensional 7 
array (a matrix) as a product of factor matrices, tensor decompositions allow us to extract 8 
from seemingly complex multidimensional data parsimonious and unique representations of 9 
underlying patterns 11,12. Since the introduction of the PARAFAC algorithm, which 10 
decomposes a tensor into a sum of outer products of low-rank components 13, tensor 11 
decompostions, and PARAFAC in particular, have been used in a wide range of studies of EEG 12 
activity 14. Seminal studies focused on the analysis of event-related potentials 15,16. 13 
Subsequent tensor decompositions of EEG data enabled the inspection of time-frequency 14 
representations of EEGs during cognitive states 17. Tensor decomposition has also been used 15 
in artefact rejection and estimation of seizure onset zone 18,19. Other applications include 16 
localisation of EEG sources 20, connectivity estimation 21, brain computer interfaces 22,23, and 17 
feature extraction in clinical and psychological studies 24-26. Tensor decomposition are also 18 
useful when fusing EEG with other datasets 27-29. Overall, the use of tensor decompositions is 19 
advatageous over matrix factorisations when the data are naturally multdimensional like in 20 
the case of EEG, and TMS-EEG 12. 21 
In this study, we sought to apply a data-driven approach, exploting the multidimensional 22 
structure of previously collected TMS-EEG data, allowing a parsimonious dimensionality 23 
reduction that summarises effects in the high-dimensional data. We hypothesise that 24 
PARAFAC will be able to reveal underlying patterns of activity with different topographical 25 
(accounting for the spatial distribution of a brain network), temporal (indicating time period 26 
after TMS stimulation during which the network is active) and spectral (informing about the 27 
typical operating frequency of the network) profiles that will be characteristic of the effects 28 
of each type of anti-epileptic drug (AED) in the TMS-EEG data without a-priori assumptions. 29 
 30 
2. Methods 1 
2.1 Subjects 2 
Thirteen healthy male volunteers aged 19-34 years (mean age 25.2 years, SD = ± 4.62) 3 
participated in the study after written informed consent was given. All subjects were classified 4 
as right-handed according to the Edinburgh Handedness Inventory 30 and underwent physical 5 
examination and screening for any contraindications to TMS or study drugs 31. The College 6 
Research Ethics Committee (CREC) of King’s College London approved the research, which 7 
was performed in accordance with relevant guildlines and regulations. Informed consent was 8 
obtained from all participants. The TMS-evoked EEG potential (TEP) analyses of this sample 9 
have been published previously 7,32.  10 
2.2 Experimental design  11 
We performed a double-blind, randomized, placebo-controlled, crossover study to 12 
investigate the impact of levetiracetam (LEV, 3000 mg) and lamotrigine (LTG, 300mg) on TMS-13 
induced EEG oscillations. Each subject participated in three experimental sessions in total, 14 
administered lamotrigine, levetiracetam or placebo in each session in a randomized order, 15 
spaced at least one week apart to allow a washout period. At each session, we first performed 16 
baseline pre-drug TMS-EEG recording. Later, the post-drug recording was performed two 17 
hours after drug ingestion, please see the details of the experimental setting and protocol in 18 
the supplementary section A.1.  19 
2.3 Data analysis 20 
2.3.1 TMS-EEG data construction 21 
TMS-induced oscillations were analysed using MATLAB® (Mathworks Ltd, USA, R2012b) (The 22 
Mathworks Inc.) and FieldTrip toolbox 33. After excluding records/trials with prominent eye 23 
movements, blinks, and muscle artefacts (on the basis of visual inspection), EEG data was 24 
analyzed using an established multistep procedure 34. Data was down sampled to 1 kHz, 25 
segmented 1 s before and after the pulse, and linearly interpolated for ±10 ms to remove the 26 
TMS artefact. Bad channels were removed from the EEG, and the signal was reconstructed by 27 
interpolating the surrounding electrode signals. Data was then notched filtered (50 Hz). 28 
Independent Component analysis (ICA) was applied to remove TMS-related artifacts (i.e., the 29 
cranial muscle response, the recharging of capacitors, and related exponential decay artifacts 1 
35-37, as well as further muscle and ocular activity. Finally, remaining data were re-referenced 2 
to the average of all electrodes, baseline corrected (from -1000 to -50 ms) and band-pass 3 
filtered (1-80 Hz).  4 
After that, for each segment we estimated its time-frequency plot by applying a Hanning 5 
taper windowed fast Fourier transform (FFT) with frequency-dependent window length 6 
(width: 3.5 cycles per time window, time steps: 10 ms, frequency steps: 1 Hz from 4 to 45 Hz) 7 
38. TMS-induced responses were obtained by subtracting the individual time-domain average 8 
from each trial before calculating the TF of the single trials 39. We performed single-trial 9 
normalization by z-transforming the TF of each trial for each frequency. The z-transformation 10 
was based on the respective mean and standard deviation derived from the full trial length. 11 
This was followed by an absolute baseline correction for each trial, by subtracting the average 12 
of the 100 to 50 ms period for each frequency to ensure z-values represented a change from 13 
pre-TMS baseline. 14 
At the end, we had an array of 61 x 42 x 201 elements (61 channels, 4 Hz to 45 Hz with 15 
frequency resolution of 1Hz, and data starting from -1000 to +1000 ms with time step of 10 16 
ms). Note that, to minimise TMS and DC shifts effects along the time (3rd dimension) and 17 
frequency (2nd dimension) axes, we selected the data starting from 40 ms after the TMS pulse 18 
to 1000 ms after the TMS pulse and frequency bins between 4 to 34 Hz resulting in a new 3D 19 
array of 61 × 31 × 98 elements. These steps were repeated for all segments and all channels. 20 
2.3.2 Tensorisation of TMS-EEG data and PARAFAC modelling 21 
The TMS-EEG data construction described in section 2.3.1 resulted in a three dimensional 22 
tensor [channel (or space) × frequency × time], representing a time varying spectrum of all 23 
channels. Tensors are multi-dimensional data arrays that extend vectors (one dimensional) 24 
and matrices (two dimensional) to more than two dimensions 11,12. This three-dimensional 25 
tensor [channel (or space) × frequency × time] will be used in our subsequent tensor 26 
decomposition based analysis. Figure 1 illustrates the principle of tensor decomposition 27 
based on the PARAFAC model for our tensorised TMS-EEG data (as a 3D tensor for simplicity). 28 
Assuming that we have a 3D tensor W, this data array can be approximated as a sum of N 1 
rank-one tensors, which represent underlying components 17,40. Each component is an outer 2 
product of three matrices (A, B and C) as: 3 
𝑤𝑤𝑖𝑖𝑖𝑖𝑖𝑖 ≈  �𝑎𝑎𝑖𝑖𝑖𝑖 ∙ 𝑏𝑏𝑖𝑖𝑖𝑖 ∙𝑛𝑛
𝑖𝑖=1
𝑐𝑐𝑖𝑖𝑖𝑖 ,              (1) 4 
where 𝑤𝑤𝑖𝑖𝑖𝑖𝑖𝑖  is an element in the tensor W, which is approximated by the summation of N rank-5 
1 components which are the outer product of 𝑎𝑎𝑖𝑖𝑖𝑖 ∙ 𝑏𝑏𝑖𝑖𝑖𝑖 ∙ 𝑐𝑐𝑖𝑖𝑖𝑖  , where, for example, 𝑎𝑎𝑖𝑖𝑖𝑖  is an 6 
element in the matrix A which contains the profiles of the extracted components along the 7 
first dimension (channel or space). Likewise, B and C contains the estimated components 8 
along the second (frequency) and third (time), respectively, see Figure 1 (A and B). This data 9 
model assummes that the neural generators resulting in the scalp EEG activity are stationary 10 
during the recording period.  11 
2.3.3 Selecting the optimum number of components 12 
There is no a priori means to determine how many components will best represent the data. 13 
Explained varinace were used to help estimate an appropriate number of components in 14 
PARAFAC.  15 
To estimate the optimal number of components, we decomposed a 5D tensor (consisting of 16 
all conditions from all subjects [61 × 31 × 98 × 13 × 6 elements]) into a different number of 17 
components ranging from one to eight (n=1,..,8 in equation 1), and estimated the explained 18 
variance in each instance. The selection of a relatively low number of components reduces 19 
the chances of overfitting and faciltiates its intepretation. More importantly, the 20 
topographical, temporal and spectral profiles of the extracted components were inspected to 21 
determine a number of PARAFAC components that would aid in the interpretation of the data. 22 
It is important to inspect the profiles of components extracted for each  considered value of 23 
n since it is not guaranteed that the components extracted when computing PARAFAC with 24 
n–1 will appear again when doing so with n components 13.  25 
Besides estimating the explained varaince, we also estimated the core consistency diagnosis 26 
(CORCONDIA, see the supplementary section A2) 41. CORCONDIA is a heuristic measure to 27 
check if the data can be modelled fully multilinearly. 28 
2.3.4 Using tensor decomposition to characterise and contrast effects of AEDs and placebo 1 
Building on the 3D tensor described above, we constructed a five dimensional tensor 2 
consisting of the three previously described dimensions (space, frequency, time) and adding 3 
two further dimensions, subject and condition (see Figure 2), by stacking 3D tensors obtained 4 
from section 2.3.2 in order to account for all the interactions of space, time and EEG 5 
oscillation frequency with the effects of drugs on the subjects. We then tested the effects of 6 
drugs on the subjects by contrasting conditions in four different ways, and including these 7 
conditions in the 5th dimension (condition): 8 
Model 1: We also use this model as a proof of concept to study the components obtained 9 
from PARAFAC without any effect from drug in order to validate the tensor decomposition 10 
of TMS-EEG data. 11 
Model 2: To test the hypothesis that levetiracetam and lamotrigine have different effects, 12 
we included four conditions: pre-LEV, post-LEV, pre-LTG, post-LTG. 13 
Model 3: To test the hypothesis that levetiracetam has a different effect than placebo, we 14 
included four conditions: pre-placebo, post-placebo, pre-LEV, post-LEV. 15 
Model 4: To test the hypothesis that lamotrigine has a different effect than placebo, we 16 
included four conditions: pre-placebo, post-placebo, pre-LTG, post-LTG. 17 
These four separate models allow us to first validate the application of PARAFAC to TMS-EEG 18 
data and then to compare in pairs the effect of each drug between them and versus placebo 19 
in data-driven, unsupervised way. Considering the post processed data (3D tensors) obtained 20 
from step 2.3.2, for each subject (per condition) we had a data array of 61 × 31 × 98 elements. 21 
After stacking these 3D tensors from all subjects for the specific conditions as described in 22 
each model, we obtained a 5D tensor of 61 × 31 × 98 × 13 × 4 elements. Unlike the example 23 
in Figure 1, showing the decomposition of the 3D tensor, with the newly constructed 5D 24 
tensor we could decompose this 5D array into a sum of 5 rank-one tensors (space (or 25 
channel), frequency, time, subject, and condition). 26 
In this study, we used the N-way toolbox version 3.3 for tensor decomposition 42 27 
(http://www.models.life.ku.dk/nwaytoolbox). Note that we applied the non-negativity 28 
constraint to all dimensions while performing decomposition. Thus every element in the 29 
decomposed arrays would be at or greater than zero 14,17,43. This constraint was imposed for 1 
a ease of interpretation.  2 
2.3.5 Statistics 3 
We applied a permutation based analysis to test for significant difference between pre-vs-4 
post drug. All steps taken are presented as follows (see the graphical representation of all the 5 
steps in the supplementary Figure A1). At each model, we first decomposed the 5D tensor 6 
(with 61 x 31 x 98 x 13 x 4) into three components. These components were considered as 7 
‘master’ components (that is, the ‘true labelled’ components, in distinction to permuted 8 
components, see below). Each of these components consisted of five profiles across the five 9 
dimensions (axes). For example in model-1, at each component we obtained five rank-1 10 
tensors with 61, 31, 98, 13, and 4 elements for space, frequency, time, subject and condition, 11 
respectively.  12 
Then we permuted this 5D tensor for 1,000 iterations. At each iteration, we permuted the 13 
elements on the 4th and 5th dimensions (subjects and conditions). Next, we decomposed this 14 
permuted 5D tensor while fixing all elements in the first three tensors. From this step, we 15 
obtained a new set of five rank-1 tensors, where thre first three tensors (representing space, 16 
frequency and time) were similar to the ones in the master, but the elements in the 4th and 17 
5th tensors could be different from the master because shuffling the data along those 18 
dimensions destroys the inherent structure.  19 
To assess the effects after drug/placebo intake, we subtracted the value on the 5th dimension 20 
of the pre drug from the value post drug. For example, considering the 2nd component of the 21 
master (true label), we subtracted the value before LEV intake from the value after LEV intake 22 
see the supplementary Figure A1). For the permuted data, at each iteration we estimated the 23 
level of change post drug as we did with the master. Then, we computed a histogram of these 24 
values. The level of change in master (true label) was significant if its value was less (or 25 
greater) than 2.5% of the distribution of the histogram. Note that the green square in the 26 
histogram at the bottom tight of the supplementary Figure A1 represents the difference 27 
between pre-vs-post LEV, where the two red vertical lines represent the upper and lower 28 
2.5% of the histogram. 29 
2.4 Data and code availability statement 30 
Data and code are available upon request. 1 
3. Results 2 
3.1 Optimum number of decomposed components 3 
We first explored our data to determine the optimal number of components. We 4 
decomposed the 5D tensor (space, frequency, time, subject, condition) build from all subjects 5 
and all six conditions into a range of number of components from one to eight. First, we 6 
showed the percentage of explained variance at different number of components in Table 1. 7 
Then, we showed the topographical, temporal and spectral profiles of the extracted 8 
components from all eight cases (see the supplementary Figures A2-A4).  9 
From Table 1, a marked change was found in these parameters when increasing the number 10 
of components from one to three: i.e. ~10% increase in terms of explained variance. Above 4 11 
components, further increasing the number of components did not significantly change either 12 
of these parameters.  13 
In the supplementary Figure A2, representing the decomposed components on the 1st 14 
dimension (space), we found three typical underlying spatial patterns (highlighted in green, 15 
red and blue), which were relatively consistent (at least 6 out of 8 scenarios).  16 
Moving on to the frequency axis (2nd dimension), if we decomposed the 5D tensor into a 17 
single component, this component would be represented primarily in the alpha range, see 18 
the supplementary Figure A3. When decomposing the same 5D tensor into two components, 19 
a component primrily in the theta frequency range was found in addition to the alpha 20 
component. Decomposed into three components, we observed they were distinct, primarily 21 
in theta, alpha and beta bands. After that, increasing the number of components did not add 22 
any other distinct components at other frequency bands, as most of the further decomposed 23 
components overlapped with the components found when decomposed into just three. 24 
Finally, in the time axis unlike the first two axes it was harder to justify a number of 25 
independent components. By visual inspection, at least three distinct components were 26 
found, see the supplementary Figure A4.  27 
Taking these together, we decided to decompose the 5D tensor into three components where 1 
the three distinct frequency band and three unique spatial patterns were clearly observed 2 
and the explained variance reached its plateau at about 40%. 3 
3.2 Comparison across the four models 4 
Figure 3 shows three components decomposed from our four different models. The 5D tensor 5 
from each model was decomposed into three components at three different frequency bands 6 
(theta, alpha, and beta, see the 2nd column in Figure 3).  7 
The model 1 is a proof of concept showing the three physiological components (beta, alpha 8 
and theta) decomposed from the TMS-EEG data without any effect from LEV or LTG.  9 
First considering the beta components (labelled in blue) from all models, these components 10 
mostly represented frontal brain activities. On the time axis (3rd dimension), each of these 11 
beta components could be divided into 3 phases: (1) initial peak (during 40 – 200 12 
milliseconds), (2) suppression (200 – 400 milliseconds) and (3) rebound (400 milliseconds 13 
onward). When we compared between models 3 and 4 (between LTG and LEV), one could 14 
observe less rebound of this beta component in LTG as compared to LEV.  15 
The next component, which was predominantly observed in alpha range, showed the most 16 
variability (in terms of magnitude and spatial pattern) among the three components (theta, 17 
alpha, and beta) across all models. Whereas one could see the alpha component dominating 18 
occipital lobe in models 2 and 3, in model 4 this alpha activity can be seen everywhere (with 19 
high amplitude) except on the areas next to the earlobes.  20 
Moving on to the last component, or theta labelled in orange, it was spatially identical across 21 
all models and represented the activities on C3. This component reached its peak around 200 22 
milliseconds and completely suppressed starting ~400 milliseconds to the end of each 23 
recording.  24 
3.3 Model 2: comparison of the effects of levetiracetam and lamotrigine. 25 
Figure 4 shows the three decomposed components in five dimensions, which were 26 
highlighted in blue, red and orange for 1st, 2nd and 3rd components respectively. The first 27 
component (blue) represented the brain activities (in the beta range, peak at 19 Hz) over the 28 
frontal and central areas. On the time axis (3rd dimension), this component initially peaked at 29 
~90 milliseconds after applied TMS pulse, then suppressed between 190 – 400 milliseconds, 1 
and rebounded from 440 milliseconds to the end of the recording.  2 
The second component (red) represented the activities with relatively lower frequency (at 3 
alpha band or between 6 - 13 Hz), which predominantly involved the occipital lobe. Initially, 4 
during 40 – 140 milliseconds after the TMS pulse, while the 1st component (frontal beta) was 5 
reaching its peak, this component (occipital alpha) was absent. Subsequently, during 140 – 6 
340 seconds, while the 1st component was declining and eventually completely diminished, 7 
this 2nd component was on the rise and reached a plateau. Starting from 440 milliseconds 8 
until the end of the recording, these two components coexisted.  9 
The last component (3rd, orange) was found in the theta band (4-6 Hz), centered on EEG 10 
electrode C3, which was the location where the TMS pulses were given. This component 11 
reached its peak between 90 – 240 milliseconds, and later was suppressed starting from 440 12 
milliseconds until the end of recording (which was the period where both 1st and 2nd 13 
components coexisted).  14 
Inter-subject variabilities were revealed in the 4th dimension showing the 1st , 10th and last 15 
subject being different from the others. On the 5th dimension condition (drug) effects were 16 
revealed, and we observed reduction in all components after receiving medication (both LEV 17 
and LTG). From this plot, one could see a stronger post medication effect for LEV as compared 18 
to LTG, especially in the 2nd component. At a group level, there was a significant effect of 19 
reduction of the 2nd component after LEV intake (see Figure 5).  20 
3.4 Statistics 21 
Figure 6 shows distributions of difference between pre-and-post medication from 1000 22 
iterations in models 2, 3 and 4. Statistically, no significant change in either theta or beta 23 
components was found (see columns 1 and 3). Considering models 3 and 4, when we 24 
investigated the effects after drug vs after plecebo, we found significant reduction of alpha 25 
component in both  post LEV (p=0.015*) and post LTG (p=0.021*) conditions. In model 2, 26 
when we compared the effects after drug intakes in both LEV vs LTG, the post-LEV shows a 27 
significantly stronger reduction of the alpha component than post-LTG with p=0.01*.  28 
 29 
4. Discussion 1 
In this study, we introduced a tensor decomposition method to reduce multi-dimensionality 2 
of TMS-EEG data. We showed a series of components which provides a parsimonious 3 
description of neurophysiological responses underlying TMS-induced oscillations. In addition 4 
we demonstrated the utility of PARAFAC on existing data to disentangle the effect of anti-5 
epileptic drugs on TMS-indueced oscillations. This method does not require a-priori selection 6 
of anatomical regions of interest, time periods of interest and frequency components of 7 
interest in the multi-dimensional EEG data, and without requiring potentially harsh post-hoc 8 
statistical correction for multiple comparisons. PARAFAC revealed an effect of both 9 
levetiracetam and lamotrigine, significantly suppressing oscillations in the alpha range in the 10 
occipital region, during the time period approximately 140 ms - 840 ms after the TMS pulse. 11 
Furthermore, this technique also reveals that the suppression of alpha oscillations is 12 
significantly stronger during the intake of levetiracetam than lamotrigine.  13 
4.1 Optimum number of decomposed components and justification of PARAFAC model  14 
From Table 1, the explained variance in the data reached its plateau when splitting into three 15 
components. This suggsests three as the optimal components. To justify our choice, we also 16 
visually inspected the decomposed profiles on space, time and frequency axes 17 
(supplementary Figures A2 – A4). This is important as the profiles of components extracted 18 
for each  considered value of n since it is not guaranteed that the components extracted when 19 
computing PARAFAC with n–1 will appear again when doing so with n components 13. The fact 20 
that similar patterns appeared naturally provides further support to the interpretability of our 21 
chosen model. The inspection of the components also enabled us to grasp which physiological 22 
processes captured by the data-driven components were prominent in the TMS-EEG 23 
recordings. The results support our choice of 3 components. It was clear that along the 24 
frequency axis (supplementary Figure A3) regardless of the number of decomposed 25 
components we could only break down into maximum three different frequency bands 26 
(theta, alpha, and beta). Moving on to the spatial axis (the supplementary Figure A2), it was 27 
debatable if a maximum number of components could be either three or four. Finally, along 28 
the time axis (the supplementary Figure A4), the optimal number of component was unclear 29 
(it could either be any number between two to  four). Looking at the CORCONDIA in the 30 
supplementary Table A2, we found that by extracting more than one component the value of 31 
CORCONDIA drop to zero. This suggests our 5D tensor is not a fully multilinear form and also 1 
explains the non-equivalent number of optimal components along different axes 41. Taking all 2 
these together, we then decided to decompose into three components, where all three 3 
unique signatures along frequency and spatially domains were found, and the explained 4 
variances reached its plateau. It is important to note that the explained variance may not 5 
increase significantly with the number of components since the multilinear PARAFAC model 6 
will not explain the noise and random variations in the data. Furthermore, increasing the 7 
number of components would lead to higher computational cost 44.  8 
Although another family of tensor decompositions (Tucker decompositon) may provide a 9 
solution to the case with a non-equivalent number of optimal components, it does not 10 
preserve one-to-one interaction 33,45. Hence, the decomposed components using Tucker 11 
decomposition are harder to interpret. To sum up, we decided to decompose the TMS-EEG 12 
5D tensor using PARAFAC, which preserves one-to-one interaction. That is each component 13 
will be entitled to a unique interpretation, for example, the TMS induced component may be 14 
seen in a particular frequncy range, anatomical distribution and time period. Future work will 15 
explore the suitability of other more flexible, but still unique models such as PARAFAC2 21, to 16 
improve the modelling of TMS-EEG data and reveal even more subtle interactions. 17 
4.2 Physiological meanings behind the three components  18 
From model 1 (without drug) we found three physiological components (theta, alpha and 19 
beta), these components are highly similar (spatially, temporally and spectrally) across four 20 
models, see Figure 3. Given that the PARAFAC solution is unique under very mild conditions, 21 
this further reinforces that the extracted components have physiological meaning. These 22 
components (frontal-sensorimotor beta, posterior alpha and theta related to the site of 23 
stimulation) represented the hidden signature of the data for all conditions (pre/post PLA, 24 
pre/post LEV, pre/post LTG). We considered the frontal-sensorimotor beta component to 25 
represent the spreading of cortical reactivity from the stimulated site (C3) through its 26 
neighboring areas via local fibers as well as to the contralateral motor cortex via corpus 27 
callosum 46. Sensorimotor rhythms, which dominate the motor cortex, are found in mu (8-13 28 
Hz) and beta rhythms (15-30 Hz) 47,48. By giving a TMS pulse, it may elicit similar effects on the 29 
cortical neurons seen as event-related (de)-synchronization (ERD/ERS) time locked to motor 30 
movement over motor cortex areas 49-51. Since the rebound of sensorimotor rhythms 31 
(synchronization) is uniquely observed in the beta range after giving stimuli 49,50, by imposing 1 
the non-negativity constraint to the 5D tensor we might limit the decomposed component at 2 
this area only in the beta band. Moving on to the posterior alpha, it is found to be a key 3 
component shown to differentiate between the two drugs, seen as the stronger reduction of 4 
alpha component after LEV compard to LTG intake, in model 2. Considering both models 3 5 
and 4 (placebo vs each type of drug), we found the significant reduction of this component 6 
after both LEV and LTG intake (whereas no change was found post placebo). Results suggest 7 
that both types of drug cause similar effects on the generation of posterior alpha. The same 8 
observation derived from the investigation of these AEDs on TEPs, where despite the varying 9 
profile of effects and regardless of the (putative) molecular targets of the different drugs, 10 
systemically administered LEV and LTG exert similar modulation of TEPs (Premoli et al 2017). 11 
In addition, the effect on alpha was stronger under LEV exposure which had the highest 12 
average concentration in blood outside the reference range, with LTG averaging toward a 13 
lower concentration for its reference range (Premoli et al 2017).  14 
Lastly, considering theta, this component represents the TMS-induced effect on the 15 
stimulation site, because its spatial pattern was centred on C3 and its temporal signature 16 
shows a peak soon after stimualtion and then subsided.  17 
 18 
4.3 Strengths and weaknesses of this study 19 
Unlike a conventional TMS-EEG analysis, which requires predefining time, anatomical area 20 
and frequency of interest, tensor decompositions offer a purely data-driven approach. In 21 
particular, we applied PARAFAC due to its parsimony and ease of interpretation since the 22 
interactions of the components are restricted. In our analysis, the 5D tensor for each mode 23 
had dimensions 61 × 31 × 98 × 13 × 4 (9,636,536 entries in total). Decomposing it with 24 
PARAFAC, the method was able to account for approximately 40% of the explained variance 25 
with just 3 components which include only 621 elements – i.e., 3 × (61 + 31 + 98 + 13 + 4), less 26 
than 0.01% of the total number of entries in the tensor. The results were tested under 27 
permutation-based statistics. We successfully showed that each decomposed component 28 
represents the unique signature on the spatial, spectral and temporal domains with 29 
physiological meaning. Furthermore, along the 4th dimension, one could make the inference 30 
about these hidden signatures at a single subject level. Despite the postive results provided 1 
by this innovative analysis approach of TMS-EEG data, it must be take into consideration that 2 
the TMS pulse can induce unwanted somatosensory input that have an impact on TEPs 52.  We 3 
purposely selected a PARAFAC model with non-negativity constraints to simplify the 4 
interpretation of the components extracted from TMS-EEG activity in this first application of 5 
tensor decompositions to this type of data. However, we acknoledge that the choice of the 6 
non-negativity constraint implies that we were not able to reveal potential patterns in 7 
negative values and that our results are also limited by the small number of participants and 8 
we advice the reader to intepret them with care.  9 
5. Conclusion  10 
To our knowledge, it is the first time tensor decomposition has been applied in TMS-EEG data. 11 
Our results show the power of tensor decompositions to reveal the profiles underlying the 12 
complex responses in TMS-EEG data associated with different AEDs in healthy subjects in a 13 
data-driven and parsimonious way. Future work will seek to develop classifiers able to predict 14 
the level of response to each AED in new subjects by projecting their TMS-EEG recordings on 15 
the “characteristic filters” associated with previously revealed tensor components in space, 16 
time and frequency 26,53. We will also consider the possibility of applying tensor 17 
decompositions to TMS-EEG signals in the time domain following other previous applications 18 
of these techniques to event-related EEG activity 14. 19 
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Table 1:  Percentage of explained variance by a number of decomposed components 1 
Scenario 
No. of  Explained 
Components variance (%) 
I 1 29.14 
II 2 34.06 
III 3 39.33 
IV 4 41.21 
V 5 42.53 
VI 6 43.49 
VII 7 44.05 


















List of Figures 1 
Figure 1A shows N decomposed components from the 3D tensor W, each component comprises three 2 
vectors (A, B and C). Figure 1B shows an example when the technique was used to decompose the 3D 3 
(space x frequency x time) of subject#2 post LEV. In this case, the three components represent high, 4 
medium and low-frequency ranges (15-30 Hz "Beta", 6-13 Hz "Alpha", and 4-6 Hz “Theta”. The bottom 5 
two insets show a Space-vs-Frequency plot at 150 milliseconds after TMS pulse and its grand average 6 
across all channels.   7 
Figure 2: The five-dimensional tensor in this study comprises of space (channel), frequency, time, 8 
subject and condition (1st, 2nd, 3rd, 4th and 5th dimension, respectively).  9 
Figure 3: We present the three components decomposed from 5D tensor in four different models. The 10 
top row shows the decomposed components in space (topographical plots), frequency and time 11 
dimension. Three colours (blue, red and yellow) are used to indicate the three decomposed 12 
components: beta (with peak frequency between 15-30 Hz), alpha (with peak frequency between 6-13 13 
Hz) and theta (with peak frequency between 4-6 Hz), respectively.  14 
 15 
Figure 4: The three components decomposed from the 5D tensor in all subjects during pre-drug and 16 
post-drug conditions with LEV or LTG. Note that: D stands for Dimension. 17 
Figure 5: Each histogram shows the distribution of strength on the 5th dimension obtained from 1000 18 
iterations of permutation.  Two vertical red lines indicate the upper and lower 2.5% of the histogram. 19 
Each green square oindicates the difference between pre and post medication on the 5th dimension. In 20 
the top and bottom rows (showing the results from components 1 and 3, respectively), no significant 21 
reduction was found. For component #2 (middle row), we observed the significant reduction in terms 22 
of strength on the 5th dimension after receiving LEV.  23 
Figure 6: Each histogram shows the distribution of difference between pre and post medication(or 24 
placebo) from 1000 iteration. The two red lines in the histograms indicate the first and last 2.5 percent. 25 
The green square represents the post vs pre difference on the 5th dimension. * denotes significant 26 
(P<0.025). All histograms on the top, middle and bottom rows are the distribution from model 2, 3, 27 
and 4, respectively. Note that all the p-values in this study are reported in the supplementary Table A1.  28 
 29 
 30 
